235 related articles for article (PubMed ID: 8627110)
1. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
[TBL] [Abstract][Full Text] [Related]
2. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
[TBL] [Abstract][Full Text] [Related]
3. Immunological upgrading with combined immunotherapy and chemotherapy in a lepromatous leprosy patient: a case report.
Zaheer SA; Suresh NR; Kar HK; Sharma AK; Mukherjee A; Mukherjee R; Talwar GP
Lepr Rev; 1991 Sep; 62(3):297-302. PubMed ID: 1795588
[TBL] [Abstract][Full Text] [Related]
4. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG.
Convit J; Aranzazu N; Pinardi M; Ulrich M
Clin Exp Immunol; 1979 May; 36(2):214-20. PubMed ID: 383331
[TBL] [Abstract][Full Text] [Related]
5. Histological changes with combined chemotherapy and immunotherapy in highly bacillated lepromatous leprosy.
Natarajan M; Katoch K; Bagga AK; Katoch VM
Acta Leprol; 1992; 8(2):79-86. PubMed ID: 1293915
[TBL] [Abstract][Full Text] [Related]
6. Effects of ICRC antileprosy vaccine in healthy subjects.
Chaturvedi RM; Chirmule NB; Yellapurkar MV; Shaikh SU; Deo MG
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):657-66. PubMed ID: 3323368
[TBL] [Abstract][Full Text] [Related]
7. Lepromin conversion in repeatedly lepromin negative BL/LL patients after immunization with autoclaved Mycobacterium w.
Chaudhuri S; Fotedar A; Talwar GP
Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):159-68. PubMed ID: 6684642
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapeutic potential of ICRC vaccine: a case control study.
Bhatki WS; Chulawala RG
Lepr Rev; 1992 Dec; 63(4):358-64. PubMed ID: 1479876
[TBL] [Abstract][Full Text] [Related]
9. Induction of lepromin positivity by a candidate anti-leprosy vaccine Mycobacterium w in lepromin negative healthy contacts of multibacillary leprosy patients.
Kar HK; Sharma AK; Misra RS; Zaheer SA; Mukherjee A; Mukherjee R; Beena KR; Kaur H; Nair SK; Talwar GP
Indian J Lepr; 1992; 64(4):495-500. PubMed ID: 1308525
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of human volunteers with heat-killed M. leprae: local responses in relation to the interpretation of the lepromin reaction.
Gill HK; Mustafa AS; Godal T
Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):36-44. PubMed ID: 3286799
[TBL] [Abstract][Full Text] [Related]
11. Histopathological monitoring of an immunotherapeutic trial with Mycobacterium w.
Mukherjee A; Zaheer SA; Sharma AK; Misra RS; Kar HK; Mukherjee R; Talwar GP
Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):28-35. PubMed ID: 1602191
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of treated BL/LL cases with BCG: histopathological, immunohistological and bacteriological assessments.
Katoch K; Natrajan M; Narayanan RB; Katoch VM
Acta Leprol; 1989; 7 Suppl 1():153-5. PubMed ID: 2503975
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic "subunit" of the ICRC antileprosy vaccine.
Chirmule NB; Chaturvedi RM; Deo MG
Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):27-35. PubMed ID: 3131465
[TBL] [Abstract][Full Text] [Related]
14. Immunological properties of M. leprae culture isolates ICRC bacilli: hypothesis on relationship between M. leprae and ML-culture isolates.
Bapat CV
Acta Leprol; 1984; 2(2-4):175-94. PubMed ID: 6442820
[TBL] [Abstract][Full Text] [Related]
15. Reversal reaction in lepromatous patients induced by a vaccine containing killed ICRC bacilli--a report of five cases.
Bhatki WS; Chulawala RG; Bapat CV; Deo MG
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):466-72. PubMed ID: 6368413
[TBL] [Abstract][Full Text] [Related]
16. Antigeneic cross-reactivity between ICRC-bacilli and M. leprae--"in vitro" evaluation.
Kale VP; Bapat CV
Indian J Lepr; 1984; 56(2):219-31. PubMed ID: 6387004
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
Bapat CV; Modak MS; DeSouza NG; Chulawalla RG
Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
[TBL] [Abstract][Full Text] [Related]
18. A bacteriological assessment of multibacillary cases in leprosy colonies after 4 1/2 years of multidrug therapy.
Naik SS; Bhanage ND; Sawant KV; Ganapati R
Indian J Lepr; 1988 Jul; 60(3):393-9. PubMed ID: 3058827
[TBL] [Abstract][Full Text] [Related]
19. Antileprosy potentials of ICRC vaccine. A study in patients and healthy volunteers.
Deo MG; Bapat CV; Bhalerao V; Chaturvedi RM; Bhatki WS; Chulawala RG
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):540-9. PubMed ID: 6368417
[No Abstract] [Full Text] [Related]
20. Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test.
Job CK; Chacko CJ; Taylor PM; Daniel M; Jesudian G
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):256-66. PubMed ID: 776862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
